You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 4, April 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Bilateral neuralgic amyotrophy induced by interferon treatment

P. L. Bernsen, R. E. Wong Chung, H. M. Vingerhoets and J. T. Janssen
Institute of Neurology, St Radboud University Hospital, Nijmegen, The Netherlands.

Neurologic side effects of interferon therapy usually consist of diffuse involvement of the central and peripheral nervous systems. We describe a patient with hairy cell leukemia who developed bilateral neuralgic amyotrophy, sacral radicular irritation, and worsening of a preexistent polyneuropathy during treatment with recombinant interferon. A sample of the patient's cerebrospinal fluid showed an increased protein content and oligoclonal banding. Several weeks after discontinuation of interferon therapy, Mees-Beau lines became evident on the patient's fingernails. The findings in this patients, as well as those recently reported by others, show that focal neurologic disturbances may be induced by interferon therapy. The clinical picture of neuralgic amyotrophy is briefly reviewed.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neuralgic Amyotrophy Associated with Antibiotic Therapy
Finstad et al.
The Annals of Pharmacotherapy 2008;42:1344-1347.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.